Skip Navigation


Cardiovascular Research Advance Access first published online on March 7, 2008
This version [Corrected Proof] published online on April 8, 2008
Cardiovascular Research, doi:10.1093/cvr/cvn060
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
78/3/422    most recent
cvn060v2
cvn060v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Brundel, B. J.J.M.
Right arrow Articles by Kampinga, H. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brundel, B. J.J.M.
Right arrow Articles by Kampinga, H. H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org

Heat shock proteins as molecular targets for intervention in atrial fibrillation

Bianca J.J.M. Brundel1,2,*, Lei Ke1, Anne-Jan Dijkhuis1, XiaoYan Qi3, Akiko Shiroshita-Takeshita3,4, Stanley Nattel3, Robert H. Henning2 and Harm H. Kampinga1

1 Department of Radiation and Stress Cell Biology, University of Groningen, University Medical Center Groningen, A. Deusinglaan 1, 9713 AV Groningen, The Netherlands
2 Department of Clinical Pharmacology, University Groningen, University Medical Center Groningen, Groningen, The Netherlands
3 Department of Medicine and Research Center, Montreal Heart Institute and Université de Montréal, Canada
4 Department of Emergency and Critical Care Medicine, Keio University School of Medicine, Tokyo, Japan

* Corresponding author. Tel: +31 50 3633399; fax: +31 50 3632913. E-mail address: b.j.j.m.brundel{at}med.umcg.nl

Atrial fibrillation (AF) is the most common sustained clinical tachyarrhythmia. AF is a progressive condition as demonstrated by the finding that maintenance of normal rhythm and contractile function becomes more difficult the longer AF exists. AF causes cellular stress, which induces atrial remodelling, involving reduction in the expression of L-type Ca2+ channels and structural changes (myolysis), finally resulting in contractile dysfunction. Heat shock proteins (HSPs) comprise a family of proteins involved in the protection against different forms of cellular stress. Their classical function is the prevention of toxic protein aggregation by binding to (partially) unfolded proteins. Recent investigations reveal that HSPs prevent atrial remodelling and attenuate the promotion of AF in both cellular and animal experimental models. Furthermore, studies in humans suggest a protective role for HSPs against progression from paroxysmal AF to chronic, persistent AF. Therefore, manipulation of the HSP system may offer novel therapeutic approaches for the prevention of atrial remodelling. Such approaches may contribute to the maintenance or restoration of tissue integrity and contractile function. Ultimately, this concept may offer an additional treatment strategy to delay progression towards chronic AF and/or improve the outcome of cardioversion.

KEYWORDS Atrial fibrillation; Heat shock proteins; Geranylgeranylacetone; Hsp27; HspB1; HL-1

Time for primary review: 27 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cardiovasc ResHome page
S.-M. Chaldoupi, P. Loh, R. N.W. Hauer, J. M.T. de Bakker, and H. V.M. van Rijen
The role of connexin40 in atrial fibrillation
Cardiovasc Res, July 7, 2009; (2009) cvp203v2.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.